CU20060219A7 - FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE PRINCIPLE CONTAINING VARDENAFILO - Google Patents
FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE PRINCIPLE CONTAINING VARDENAFILOInfo
- Publication number
- CU20060219A7 CU20060219A7 CU20060219A CU20060219A CU20060219A7 CU 20060219 A7 CU20060219 A7 CU 20060219A7 CU 20060219 A CU20060219 A CU 20060219A CU 20060219 A CU20060219 A CU 20060219A CU 20060219 A7 CU20060219 A7 CU 20060219A7
- Authority
- CU
- Cuba
- Prior art keywords
- controlled release
- vardenafilo
- formulations
- active principle
- principle containing
- Prior art date
Links
- 238000013270 controlled release Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 229940123333 Phosphodiesterase 5 inhibitor Drugs 0.000 abstract 1
- SECKRCOLJRRGGV-UHFFFAOYSA-N Vardenafil Chemical compound CCCC1=NC(C)=C(C(N=2)=O)N1NC=2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(CC)CC1 SECKRCOLJRRGGV-UHFFFAOYSA-N 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000002590 phosphodiesterase V inhibitor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 229960002381 vardenafil Drugs 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refier a nuevas formas de presentación galénicas de liberación controlada de principio activo, que contienen el inhibidor de PDE-5 vardenafilo y/o sales,hidratos, solvatos y/o formas polimóficas del mismo farmacéuticamente eceptables como principio activo, así como a su preparación, La invención se refiere además al uso de estas nuevas formas de presentación galénicas como medicamentos y a su uso para la preparación de medicamentos para el tratamiento y/o prevención de enfermedades en humanos y animales.The present invention relates to new forms of galenic presentation of controlled release of active ingredient, which contain the PDE-5 inhibitor vardenafil and / or pharmaceutically acceptable salts, hydrates, solvates and / or polymorphic forms thereof as active ingredient, as well as to its preparation, The invention also relates to the use of these new forms of galenic presentation as medicaments and their use for the preparation of medicaments for the treatment and / or prevention of diseases in humans and animals.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20060219A CU20060219A7 (en) | 2006-11-13 | 2006-11-13 | FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE PRINCIPLE CONTAINING VARDENAFILO |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20060219A CU20060219A7 (en) | 2006-11-13 | 2006-11-13 | FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE PRINCIPLE CONTAINING VARDENAFILO |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20060219A7 true CU20060219A7 (en) | 2009-09-08 |
Family
ID=44280813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20060219A CU20060219A7 (en) | 2006-11-13 | 2006-11-13 | FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE PRINCIPLE CONTAINING VARDENAFILO |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU20060219A7 (en) |
-
2006
- 2006-11-13 CU CU20060219A patent/CU20060219A7/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP066990A (en) | FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE PRINCIPLE CONTAINING VARDENAFILO | |
| AR124134A2 (en) | TOPICAL USE FORMULATION FOR A JAK INHIBITOR | |
| ECSP11011198A (en) | SULFONAMIDE DERIVATIVES | |
| CO6491060A2 (en) | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITARY DISEASES | |
| CL2008000946A1 (en) | COMPOUNDS DERIVED FROM PIRROLOPIRIMIDINA, INHIBITORS OF CIANASA JAK3; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF REPLACEMENT OF TRANSPLANTS, AUTOIMMUN DISEASES | |
| UY30460A1 (en) | THERAPEUTIC COMPOUNDS | |
| CL2012000589A1 (en) | Compounds derived from pyrrolo pyridine carboxamides, jak2 inhibitors; pharmaceutical composition comprising them; use in the treatment of myeloproliferative diseases or cancer, such as polycythemia vera, essential thrombocytopenia, multiple myeloma, among others. | |
| CO6410279A2 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES DERIVATIVES OF GLUCOPIRANOSIL DIFENYLMETHANE, PHARMACEUTICAL FORM OF THE SAME, PROCEDURE FOR THEIR PREPARATION AND USES OF THE SAME FOR IMPROVED GLUCEMIC CONTROL IN A PATIENT. | |
| ECSP109934A (en) | COMPOUND - 946 | |
| UY35586A (en) | DERIVATIVES OF PIRAZOLOPIRROLIDINE AND ITS USE IN THE TREATMENT OF DISEASES | |
| DOP2010000134A (en) | SOME DERIVATIVES OF 2-PIRAZINONA AS INHIBITORS OF ELASTASA DE LOS NEUTROFILOS | |
| GT200900283A (en) | "COMBINATION THERAPY WITH A COMPOUND ACTING AS AN ADP PLAQUETARY RECEPTOR INHIBITOR". | |
| GT200600445A (en) | SOLID PHARMACEUTICAL PRESENTATION FORMS OF ORAL ADMINISTRATION WITH QUICK RELEASE OF THE ACTIVE PRINCIPLE. | |
| MX2019012847A (en) | C5-anilinoquinazoline compounds and their use in treating cancer. | |
| AR060675A1 (en) | DERIVATIVES OF N- (2-TIAZOLIL) -AMIDA AS INHIBITORS OF GSK-3, METHOD OF PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THERAPEUTIC USES. | |
| CR9954A (en) | PIRAZINE DERIVATIVES | |
| UY30282A1 (en) | CHEMICAL COMPOUNDS | |
| PA8803201A1 (en) | ACID DERIVATIVES OF CICLOALQUILAMINO | |
| UY33530A (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY AND INFLAMMATORY DISEASES | |
| PE20151607A1 (en) | ORGANIC COMPOUND FORMULATIONS | |
| UY29561A1 (en) | DERIVATIVES OF QUINAZOLINE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURES AND APPLICATIONS | |
| UY30847A1 (en) | USE OF DIANHYDROHEXITE MONONITRATE DERIVATIVES AS AGENTS FOR THE TREATMENT OF INTESTINAL DISORDERS | |
| UY31637A1 (en) | DUE PHARMACOPHORES-MUSCARINIC ANTAGONISTS OF PDE4 | |
| CL2018000391A1 (en) | Pharmaceutical combinations and their use | |
| CO6290762A2 (en) | NEW QUINAZOLIN-2, 4-DIONA DERIVATIVES AND A PHARMACEUTICAL COMPOSITION TO PREVENT TREATMENT OF NEUROCEREBRAL DISEASE |